Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib Plus Pemetrexed/Cisplatin for Lung Adenocarcinoma with Brain Metastases
NCT01578668Phase 2Completed
- Sponsor
- Guangzhou Medical University
- Start
- Jan 2012
- Primary completion
- Jan 2015
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, pemetrexed, Cisplatin micelle injection (HA132) in lung adenocarcinoma, brain metastases, sponsored by Guangzhou Medical University. Started Jan 2012; status: completed.
02
Drugs
erlotinibpemetrexedCisplatin micelle injection (HA132)
03
Conditions
lung adenocarcinomabrain metastases
Beyond the preview
Go deeper on NCT01578668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01578668.